Clinical trial · people

GHRP-2: height velocity rose to 6.1 cm/year in short children

Checked against the paper Clinical trialPublished by PepVault

The takeaway

In a small, uncontrolled study, nasal GHRP-2 was linked to a modest rise in children's growth rate without a measurable rise in IGF-1.

Kind
Clinical trial
Studied in
People
Number studied
15
Published
1997
Journal
J Endocrinol

What they tested

The team tested whether GHRP-2 given as a nasal spray could speed growth in children with short stature.

How the study was done

An uncontrolled clinical trial in 15 children with short stature, half with growth hormone (GH) deficiency and half with short stature of unknown cause. The trial's spray dose was 5-15 micrograms/kg, given two times daily for the first 3 months and three times daily after that; all 15 were followed for 6 months and 6 of them for 18-24 months, with no comparison group.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking GHRP-2? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Height velocity, the yearly rate of growth in height, went from 3.7 +/- 0.2 cm/year before treatment to 6.1 +/- 0.3 cm/year at 6 months, and was 6.0 +/- 0.4 cm/year at 18-24 months. IGF-1 and IGFBP-3, blood markers tied to GH, did not change significantly, and neither did the GH rise after a test dose of GHRP-2 by vein or nose. GH-binding protein (GHBP) went up significantly, reaching 688 +/- 48 pmol/l from a starting level of 439 +/- 63 pmol/l. The spray was well tolerated.

What it doesn’t show

This was a small study with no placebo or untreated group, so the growth change can't be cleanly credited to the peptide. Only 6 children were followed past 6 months.

The paper

Pihoker et al. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J Endocrinol. 1997.

The compound

More studies on GHRP-2

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking GHRP-2? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo